STAGE I PLEURAL MALIGNANT MESOTHELIOMA AJCC V7

Clinical trials for STAGE I PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 explained in plain language.

Never miss a new study

Get alerted when new STAGE I PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 trials appear

Sign up with your email to follow new studies for STAGE I PLEURAL MALIGNANT MESOTHELIOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New Three-Pronged attack tested for aggressive lung cancer

Disease control Ongoing

This early-stage study is testing if a three-part treatment plan is safe and feasible for people with operable pleural mesothelioma, a cancer often linked to asbestos exposure. The plan involves chemotherapy plus an immunotherapy drug before surgery, followed by up to a year of t…

Matched conditions: STAGE I PLEURAL MALIGNANT MESOTHELIOMA AJCC V7

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 21:56 UTC

STAGE I PLEURAL MALIGNANT MESOTHELIOMA AJCC V7

Get alerted when new STAGE I PLEURAL MALIGNANT MESOTHELIOMA AJCC V7 trials appear

New Three-Pronged attack tested for aggressive lung cancer